| Kendall M Handy, MD | |
|
2000 10th Ave, Suite 180, Columbus, GA 31901-3700 | |
| (706) 571-1519 | |
| (706) 320-8675 |
| Full Name | Kendall M Handy |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 39 Years |
| Location | 2000 10th Ave, Columbus, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316931975 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 031933 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Columbus Regional Midtown | Columbus, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbus Ambulatory Healthcare Services, Inc. | 1355244385 | 95 |
News Archive
Flexible Stenting Solutions Inc. ("FSS"), a leading developer of next generation peripheral arterial and biliary stents, announced today that it has received Conditional Investigational Device Exemption (IDE) approval for its FlexStent® Femoropopliteal Self Expanding Stent System.
U.S. Attorney Thomas Scott Woodward announced today that Cardinal Health Pharmacy Services, LLC, a company engaged in providing hospital pharmacy management services, has agreed to pay a civil penalty in the amount of $1 million for failing to account for large amounts of missing prescription drugs.
The growth of prenatal screening in Europe has reduced the number of babies being born per year with Down syndrome (DS) by an average of 54%, according to a new study published in the European Journal of Human Genetics by researchers from Massachusetts General Hospital and international Down syndrome organizations.
The last few years have witnessed critical advances in breast cancer therapies. Still, the disease afflicts one in eight American women, and scientists have yet to develop a living model with which they can study the intricacies of human breast-tumor behavior.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
› Verified 6 days ago
| Entity Name | Columbus Ambulatory Healthcare Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790733244 PECOS PAC ID: 1355244385 Enrollment ID: O20040128000790 |
News Archive
Flexible Stenting Solutions Inc. ("FSS"), a leading developer of next generation peripheral arterial and biliary stents, announced today that it has received Conditional Investigational Device Exemption (IDE) approval for its FlexStent® Femoropopliteal Self Expanding Stent System.
U.S. Attorney Thomas Scott Woodward announced today that Cardinal Health Pharmacy Services, LLC, a company engaged in providing hospital pharmacy management services, has agreed to pay a civil penalty in the amount of $1 million for failing to account for large amounts of missing prescription drugs.
The growth of prenatal screening in Europe has reduced the number of babies being born per year with Down syndrome (DS) by an average of 54%, according to a new study published in the European Journal of Human Genetics by researchers from Massachusetts General Hospital and international Down syndrome organizations.
The last few years have witnessed critical advances in breast cancer therapies. Still, the disease afflicts one in eight American women, and scientists have yet to develop a living model with which they can study the intricacies of human breast-tumor behavior.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
› Verified 6 days ago
| Entity Name | The Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255401519 PECOS PAC ID: 9830094077 Enrollment ID: O20040630000391 |
News Archive
Flexible Stenting Solutions Inc. ("FSS"), a leading developer of next generation peripheral arterial and biliary stents, announced today that it has received Conditional Investigational Device Exemption (IDE) approval for its FlexStent® Femoropopliteal Self Expanding Stent System.
U.S. Attorney Thomas Scott Woodward announced today that Cardinal Health Pharmacy Services, LLC, a company engaged in providing hospital pharmacy management services, has agreed to pay a civil penalty in the amount of $1 million for failing to account for large amounts of missing prescription drugs.
The growth of prenatal screening in Europe has reduced the number of babies being born per year with Down syndrome (DS) by an average of 54%, according to a new study published in the European Journal of Human Genetics by researchers from Massachusetts General Hospital and international Down syndrome organizations.
The last few years have witnessed critical advances in breast cancer therapies. Still, the disease afflicts one in eight American women, and scientists have yet to develop a living model with which they can study the intricacies of human breast-tumor behavior.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
› Verified 6 days ago
| Entity Name | Dhp Of Piedmont Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316202609 PECOS PAC ID: 9133378763 Enrollment ID: O20201014001431 |
News Archive
Flexible Stenting Solutions Inc. ("FSS"), a leading developer of next generation peripheral arterial and biliary stents, announced today that it has received Conditional Investigational Device Exemption (IDE) approval for its FlexStent® Femoropopliteal Self Expanding Stent System.
U.S. Attorney Thomas Scott Woodward announced today that Cardinal Health Pharmacy Services, LLC, a company engaged in providing hospital pharmacy management services, has agreed to pay a civil penalty in the amount of $1 million for failing to account for large amounts of missing prescription drugs.
The growth of prenatal screening in Europe has reduced the number of babies being born per year with Down syndrome (DS) by an average of 54%, according to a new study published in the European Journal of Human Genetics by researchers from Massachusetts General Hospital and international Down syndrome organizations.
The last few years have witnessed critical advances in breast cancer therapies. Still, the disease afflicts one in eight American women, and scientists have yet to develop a living model with which they can study the intricacies of human breast-tumor behavior.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kendall M Handy, MD Po Box 1038, Columbus, GA 31902-1038 Ph: (706) 571-1192 | Kendall M Handy, MD 2000 10th Ave, Suite 180, Columbus, GA 31901-3700 Ph: (706) 571-1519 |
News Archive
Flexible Stenting Solutions Inc. ("FSS"), a leading developer of next generation peripheral arterial and biliary stents, announced today that it has received Conditional Investigational Device Exemption (IDE) approval for its FlexStent® Femoropopliteal Self Expanding Stent System.
U.S. Attorney Thomas Scott Woodward announced today that Cardinal Health Pharmacy Services, LLC, a company engaged in providing hospital pharmacy management services, has agreed to pay a civil penalty in the amount of $1 million for failing to account for large amounts of missing prescription drugs.
The growth of prenatal screening in Europe has reduced the number of babies being born per year with Down syndrome (DS) by an average of 54%, according to a new study published in the European Journal of Human Genetics by researchers from Massachusetts General Hospital and international Down syndrome organizations.
The last few years have witnessed critical advances in breast cancer therapies. Still, the disease afflicts one in eight American women, and scientists have yet to develop a living model with which they can study the intricacies of human breast-tumor behavior.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
› Verified 6 days ago
Richard Ervin Stephens Jr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2300 Manchester Expy, Ste B001, Columbus, GA 31904 Phone: 706-324-4891 Fax: 706-576-4958 | |
Dr. Thomas Russell Stewart, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1900 10th Ave, Suite 200, Columbus, GA 31901 Phone: 706-653-8556 Fax: 706-653-9778 | |
Kim Camille Florence, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2000 10th Ave, Suite 170, Columbus, GA 31901 Phone: 267-505-4993 | |
Dr. Benjamin H Cheek, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 Hamilton Rd, Columbus, GA 31904 Phone: 706-324-4891 Fax: 706-256-2424 | |
Dr. Thomas N Malone, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2039 10th Ave, Columbus, GA 31901 Phone: 706-324-2485 Fax: 706-327-9769 | |
Charis Nailah Chambers, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 811 22nd St, Columbus, GA 31904 Phone: 706-323-1054 Fax: 706-327-6270 | |
Dr. Jacqueline H Grant, MD, MPH, MPA Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 10th Ave Ste 100, Columbus, GA 31901 Phone: 706-571-1285 |